$AVPT Cashflow Statement | Understand Stock

$AVPT

$17.31 +$0.85 (5.16%) After hours

$AVPT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, Depletion and Amortization, Total
Depreciation and amortization
Operating lease right-of-use assets expense
Foreign currency remeasurement loss
Provision for doubtful accounts
Stock-based compensation
Loss (gain) on disposal of property and equipment
Deferred income taxes
Allowance for credit loss on notes receivable
Other
Change in value of earn-out and warrant liabilities

Changes in operating assets and liabilities:
Accounts receivable and long-term unbilled receivables
Accounts receivable
Prepaid expenses and other current assets
Deferred contract costs and other assets
Accounts payable, accrued expenses and other current liabilities, and other liabilities
Operating lease liabilities
Deferred revenue
Net cash provided by operating activities

Investing activities
Maturities of investments
Purchases of investments
Cash paid in business combinations, net of cash acquired
Capitalization of internal-use software
Purchase of property and equipment
Issuance of notes receivables
Other investing activities
Net cash used in investing activities
Financing activities
Proceeds from recapitalization of Apex shares, net of transaction fees of $49,990
Redemption of redeemable convertible preferred stock
Redemption of Legacy AvePoint common stock
Purchase of common stock
Payment of net cash settlement for management options
Proceeds from warrant exercises
Proceeds from stock option exercises
Proceeds from sale of common shares of subsidiary
Repurchase of noncontrolling interest
Funds held on behalf of others
Funds released on behalf of others
Redemption of redeemable noncontrolling interest
Purchase of public warrants
Company earn-out shares settled in cash
Repayments of finance leases
Payments of debt issuance costs
Proceeds from issuance of Common stock, net of issuance costs
Collection of promissory note
Collection of non-recourse promissory note
Proceeds from issuance of Series C convertible preferred stock
Payments of transaction fees by Legacy AvePoint
Payments of transaction fees
Other financing activities
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Effect of exchange rates on cash
Supplemental disclosures of cash flow information
Income taxes paid
Income taxes
Company earn-out shares issuance
Unpaid purchase consideration transferred in connection with the business combination
Common stock issued in business combination
Property and equipment acquired under capital leases
Loan to certain acquiree shareholders

Comments